Development of Extracellular Matrices for Cranioplasty Applications
Award amount
$998,595Program and phase
SBIR · Phase IIAward year
2015Award details
- Awarding agency
- Department of Defense
- Branch
- Defense Health Agency
- Recipient company
- FABRICO TECHNOLOGY, INC.
- Proposal award date
- 2015-04-01
- Contract end date
- 2014-08-31
- UEI
- YMAJVR21PC43
- Solicitation number
- 2013.2
- Topic code
- DHP13-012
Research abstract
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- Development of antibody treatment of MDR ESKAPE Pathogen, P. Aeruginosa.
- Development of antibody treatment of MDR ESKAPE Pathogen, P. aeruginosa
- Development of Small Molecule Therapeutics Specifically Targeting Members of the Bunyavirales Order
- Non-canonical genetic code implementation with an optimized, easily scaled cell free lysate system
- Development of novel Small Molecule Antiviral Endocytosis Inhibition pathway
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
Research funding history
14 SBIR/STTR records share this UEI (2008–2025). Reported award amounts total $5,542,186. Reported amounts are not federal obligations.
Phases: Phase I, Phase II
Agencies: Department of Defense, National Science Foundation